Medicare Benefits Schedule Review Taskforce

Dermatology, Allergy and Immunology Clinical Committee

2017


Download the print-friendly PDF of this report

Important note

The views and recommendations in this Review report from the Clinical Committee have been released for the purpose of seeking the views of stakeholders.

This report does not constitute the final position on these items which is subject to:

Δ Stakeholder feedback;

Then

Δ Consideration by the MBS Review Taskforce;

Then if endorsed

Δ Consideration by the Minister for Health; and

Δ Government.

Stakeholders should provide comment on the recommendations via the online consultation tool.

All information and data contained in this report is true and correct at the time of the committee’s deliberations and writing of this report. Changes to data sources after this time may impact on the accuracy of the data.

Confidentiality of comments:

If you want your feedback to remain confidential, please mark it as such. It is important to be aware that confidential feedback may still be subject to access under freedom of information law.